Among these analytes were cytokines that are well-established in IBD such as S100A8 (which together with S100A9 forms the heterodimer calprotectin), as well as more recently implicated makers such as oncostatin M, elevated in both UC and CD and triggering receptor expressed on myeloid cells 1 (TREM1) in CD. This evidence concerns the gene OSM and inflammatory bowel disease.